Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Sofia Manicka"'
Autor:
Alexandra Lebedeva, Yulia Shaykhutdinova, Daria Seriak, Ekaterina Ignatova, Ekaterina Rozhavskaya, Divyasphoorthi Vardhan, Sofia Manicka, Margarita Sharova, Tatiana Grigoreva, Ancha Baranova, Vladislav Mileyko, Maxim Ivanov
Publikováno v:
Journal of Translational Medicine, Vol 20, Iss 1, Pp 1-14 (2022)
Abstract Background A fraction of patients referred for complex molecular profiling of biopsied tumors may harbor germline variants in genes associated with the development of hereditary cancer syndromes (HCS). Neither the bioinformatic analysis nor
Externí odkaz:
https://doaj.org/article/9b680c109ac444c3a3dd89445ab64863
Publikováno v:
Impulse: The Premier Undergraduate Neuroscience Journal (2022)
Over 50% of patients are resistant to current treatments for depression. With a lifetime prevalence of 20.6% among US adults, it is evident that the present understanding of major depressive disorder is limited, and current experimental methods are i
Externí odkaz:
https://doaj.org/article/80a6d889f2cc43d890ffaa293bfc67c7
Autor:
Alexandra Lebedeva, Yulia Shaykhutdinova, Daria Seriak, Ekaterina Ignatova, Ekaterina Rozhavskaya, Divyasphoorthi Vardhan, Sofia Manicka, Margarita Sharova, Tatiana Grigoreva, Ancha Baranova, Vladislav Mileyko, Maxim Ivanov
Publikováno v:
Journal of Translational Medicine
Journal of Translational Medicine, Vol 20, Iss 1, Pp 1-14 (2022)
Journal of Translational Medicine, Vol 20, Iss 1, Pp 1-14 (2022)
Background A fraction of patients referred for complex molecular profiling of biopsied tumors may harbor germline variants in genes associated with the development of hereditary cancer syndromes (HCS). Neither the bioinformatic analysis nor the repor
Autor:
Priyodarshan Goswamee, Remington Rice, Elizabeth Leggett, Fan Zhang, Sofia Manicka, Joseph H. Porter, A. Rory McQuiston
Publikováno v:
Neuropharmacology
Acute cognitive impairment and abuse potential of ketamine incentivizes the search for alternatives to ketamine for clinical management of treatment-resistant depression. Recently, (2R,6R) hydroxynorketamine ((2R,6R)-HNK), a metabolite of ketamine, h